Alexander Rosendahl
Overview
Explore the profile of Alexander Rosendahl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1039
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosendahl A, Vanaveski A, Pilv-Toom L, Blumfelds J, Silina V, Brekke M, et al.
Scand J Prim Health Care
. 2025 Jan;
1-8.
PMID: 39838273
Objective: Relative one-year cancer survival rates in the Baltic states are lower than the European mean; in the Nordic countries they are higher than the mean. This study investigated the...
2.
Thomsen L, Fog-Tonnesen M, Fink L, Norlin J, Garcia de Vinuesa A, Hansen T, et al.
Ren Fail
. 2017 Aug;
39(1):629-642.
PMID: 28805484
Uncontrolled activation of transforming growth factor beta (TGF-β) family members is hypothesized to participate in type 2 diabetes (T2D) dependent diabetic nephropathy (DN). We evaluated and compared downstream activation of...
3.
Cucak H, Thomsen L, Rosendahl A
Int Immunopharmacol
. 2017 Feb;
45:53-67.
PMID: 28187313
The metabolic syndrome has been demonstrated in gene deficient animals, e.g. db/db mice, to include a systemic inflammation leading to insulin resistance, obesity and type 2 diabetes (T2D). To determine...
4.
Thomsen L, Fog-Tonnesen M, Fink L, Norlin J, Garcia de Vinuesa A, Hansen T, et al.
Nephron
. 2017 Jan;
135(4):291-306.
PMID: 28064277
Background: The role of transforming growth factor-β (TGF-β) has recently gained much attention in diabetic nephropathy and kidney fibrosis. In this study, we extend this to an assessment of transcriptional...
5.
Bisgaard L, Bosteen M, Fink L, Sorensen C, Rosendahl A, Mogensen C, et al.
PLoS One
. 2016 Dec;
11(12):e0168396.
PMID: 27992511
Chronic kidney disease (CKD) leads to uremia. CKD is characterized by a gradual increase in kidney fibrosis and loss of kidney function, which is associated with a progressive increase in...
6.
Bisgaard L, Mogensen C, Rosendahl A, Cucak H, Nielsen L, Rasmussen S, et al.
Sci Rep
. 2016 Oct;
6:35234.
PMID: 27734926
Macrophages are heterogeneous and can polarize into specific subsets, e.g. pro-inflammatory M1-like and re-modelling M2-like macrophages. To determine if peritoneal macrophages (PEMs) or bone marrow derived macrophages (BMDMs) resembled aortic...
7.
von Scholten B, Rosendahl A, Hasbak P, Bergholdt R, Kjaer A, Rossing P, et al.
Cardiovasc Diabetol
. 2016 Apr;
15:67.
PMID: 27095356
Background: Low-grade systemic inflammation is considered to participate in the progression of type 2 diabetes (T2D) and in diabetic complications. Methods: To determine if circulating leukocytes were abnormally regulated in...
8.
Mayer C, Bergholdt R, Cucak H, Rolin B, Sams A, Rosendahl A
PLoS One
. 2015 Jul;
10(7):e0131306.
PMID: 26162095
Low grade inflammation is present in pre-clinical and human type 2 diabetes. In this process, several cytokines like IL-1β and inflammatory cells like macrophages are activated and demonstrated to participate...
9.
Cucak H, Fink L, Pedersen M, Rosendahl A
Int Immunopharmacol
. 2015 Jan;
25(1):30-42.
PMID: 25598292
Diabetic nephropathy (DN) is a serious complication of longstanding diabetes affecting up to 30% of all diabetes patients and is the main cause of end-stage kidney disease globally. Current standard...
10.
Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A
PLoS One
. 2014 Sep;
9(9):e107140.
PMID: 25254631
Low-grade inflammation, characterized by increased pro-inflammatory cytokine levels, is present in patients with obesity-linked insulin resistance, hyperglycemia and hyperlipidemia and considered to play a leading role to progression into type...